🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

AZALEA-TIMI 71 is another brick in the wall of Factor XI inhibitors. But how solid this wall is in patients with atrial fibrillation? Our comment now available in the #EHJ European Society of Cardiology Journals EHJ Editor-in-Chief bit.ly/4kWoR5H

NEW FRONTIERS OF PRIMARY PREVENTION. EHJ Editor-in-Chief European Society of Cardiology Journals Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study academic.oup.com/eurheartj/arti…

🚨 New study alert! 🩺 In patients with acute MI and cardiogenic shock, does pre-treatment w/ oral P2Y12 inhibitors help? 🤔💊 New evidence from the ACTION-SHOCK cohort now published in #EHJPharmacotherapy 🔗 ow.ly/s4Fq50VwgQm EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli

Fifteen reasons NOT to do PCI! Can you add to this list?

Management of dyslipidaemia in patients with comorbidities - facing the challenge European Society of Cardiology Journals academic.oup.com/ehjcvp/article…

🆕 How should we manage antithrombotic therapy in patients with chronic coronary syndrome who develop #AFib or #VTE? 🩸💊 Read the full article (open-access) in #EHJPharmacotherapy! 👉 ow.ly/M4UY50VAM9B EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli

🆕 Early use of #SGLT2i after myocardial infarction shows promise in reducing HF hospitalisations, but no mortality benefit 🚑❌⚰️ Is it time to rethink post-MI therapy? 🤔 Read more in #EHJPharmacotherapy 👉 ow.ly/gxg150VH0lA EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli

Aspirin or clopidogrel monotherapy for long-term antiplatelet therapy after PCI? Prof. Patrono and I discuss the results of the SMART-CHOICE trial and critically appraise its findings in light of the broader body of evidence. EHJ Editor-in-Chief European Society of Cardiology Journals bit.ly/4lXHO8t

#EHJPharmacotherapy 💊 EHJ-CVP Editor-in-Chief 👨‍💼 European Society of Cardiology European Society of Cardiology Journals 📚 #Cardiology #CardioEd #CardioTwitter #Cardio Mattia Galli SABOURETCardiologist Bartosz Hudzik MD PhD FESC FACC Abdulla A. Damluji, MD, PhD Biljana Parapid, MD, PhD, FESC Francesco Perone Federica Fogacci

Is SGLT2i initiation beneficial in patients with acute myocardial infarction? Relevant findings from a retrospective, propensity score matched, analysis including 89,554 patients. EHJ-CVP Editor-in-Chief Felice Gragnano European Society of Cardiology Journals Nikos Pyrpyris academic.oup.com/ehjcvp/article…

Mechanical circulatory support: when, how, and for whom. Read more on this State-of-the-Art Review in the #EHJ at doi.org/10.1093/eurhea… #MechanicalCirculatorySupport #HeartFailure @ESCardio European Society of Cardiology Journals

Educational Webinar! Join Prof Dr. Jur ten Berg & Assistant Professor Dr. Mattia Galli on May 14th (6-7 PM CET/12-1 PM EST) for insights on post-PCI care, DAPT de-escalation and pharmacogenomics. 🔗Register: us06web.zoom.us/meeting/regist… #MedTwitter #MedX #Cardiology #Cardio

New evidence on the role of lipoprotein(a) in recurrent atherosclerotic cardiovascular events. EHJ Editor-in-Chief European Society of Cardiology Journals Borge G Nordestgaard academic.oup.com/eurheartj/arti…

Mortality in male bodybuilding athletes is 5 times higher than in amateurs EHJ Editor-in-Chief European Society of Cardiology Journals academic.oup.com/eurheartj/arti…

Coronary artery bypass grafting with or without preoperative physiological stenosis assessment. Read the results of the SWEDEHEART study just published in #EHJ 👉 ow.ly/3g8350VXyVR Rocco Montone EHJ Editor-in-Chief

With almost 12,000 patients undergoing Light Trasmission Aggregometry over 20 years, this study is among the largest exploring sex-related variability in platelet reactivity, highlighting potential implications for personalized antiplatelet therapy. bit.ly/4kGEdu4

Clopidogrel is typically recommended in dual antithrombotic therapy with SAPT and a DOAC in AF patients undergong PCI. This study suggests that aspirin might also be a good option. EHJ-CVP Editor-in-Chief Felice Gragnano Nikos Pyrpyris European Society of Cardiology Journals academic.oup.com/ehjcvp/article…

Entering a New Era of Antiplatelet Therapy: the 4D-ACS trial EHJ-CVP Editor-in-Chief European Society of Cardiology Journals Felice Gragnano Nikos Pyrpyris academic.oup.com/ehjcvp/article…

💡 In a new real-world study, #finerenone improved cardiovascular outcomes compared with spironolactone and eplerenone in patients with T2DM. Read more in #EHJPharmacotherapy 🔍📝 academic.oup.com/ehjcvp/advance… EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli

🚨SGLT2 inhibitors: more than glycemic control. New insights into their cardioprotective and anticancer potential in diabetic patients. 🔍Discover emerging hypotheses in a new editorial in #EHJPharmacotherapy ow.ly/6min50WiZLO EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli